Human CD34+ cells do not express glutathione S-transferases alpha

Area of Science:

• Biochemistry
• Hematology
• Pharmacology

Background:

• Glutathione S-transferase alpha 1 (GSTA1) conjugates glutathione to busulfan, facilitating its elimination.
• Busulfan is a stem cell-selective alkylator used in chemotherapy.
• Understanding GSTA1 expression is critical for evaluating drug toxicity and developing targeted therapies.

Purpose of the Study:

• To investigate the expression of glutathione S-transferase alpha (GST alpha), specifically GSTA1, in human hematopoietic CD34+ cells and bone marrow.
• To compare GSTA1 expression in hematopoietic cells with tissues known to be resistant to busulfan toxicity, such as the liver.

Main Methods:

• Reverse transcription polymerase chain reaction (RT-PCR) was employed to detect GSTA1 messenger RNA (mRNA).
• Immunoblotting was utilized to assess the presence of GSTA1 protein.
• Expression analysis was performed on human hematopoietic CD34+ cells, bone marrow, and liver tissue, as well as on baboon CD34+ cells and dog bone marrow.

Main Results:

• Human hematopoietic CD34+ cells and bone marrow samples did not express GSTA1 mRNA.
• GSTA1 mRNA was highly expressed in human liver tissue.
• Neither baboon CD34+ cells nor dog bone marrow expressed GSTA1.

Conclusions:

• The absence of GSTA1 in human hematopoietic stem and progenitor cells may contribute to their sensitivity to busulfan.
• Human GSTA1's lack of expression in stem cells presents a potential opportunity for its use as a chemoprotective selectable marker in gene therapy.
• This research provides insights into busulfan's mechanism of action and toxicity in hematopoietic stem cells.